Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision. | Medicine (Baltimore) | 2023 | 38115241 | PubTator, text mining | PubMed |
| Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysis. | Ther Adv Neurol Disord | 2023 | 38107441 | PubTator, text mining | PubMed |
| Targeting complement in IgA nephropathy. | Clin Kidney J | 2023 | 38053977 | PubTator, text mining | PubMed |
| Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis. | Clin Kidney J | 2023 | 38053973 | PubTator, text mining | PubMed |
| Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review. | Front Bioeng Biotechnol | 2023 | 38026900 | PubTator, text mining | PubMed |
| The Posttraumatic Increase of the Adhesion GPCR EMR2/ADGRE2 on Circulating Neutrophils Is Not Related to Injury Severity. | Cells | 2023 | 37998392 | PubTator, text mining | PubMed |
| A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score. | Thromb J | 2023 | 37993892 | PubTator, text mining | PubMed |
| Comparison of in-gel and in-solution proteolysis in the proteome profiling of organ perfusion solutions. | Clin Proteomics | 2023 | 37968584 | PubTator, text mining | PubMed |
| Candidate Genes for IgA Nephropathy in Pediatric Patients: Exome-Wide Association Study. | Int J Mol Sci | 2023 | 37958966 | PubTator, text mining | PubMed |
| Modeling complement activation on human glomerular microvascular endothelial cells. | Front Immunol | 2023 | 37954621 | PubTator, text mining | PubMed |
| Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report. | Can J Kidney Health Dis | 2023 | 37942411 | PubTator, text mining | PubMed |
| Plasma proteomic profiling of bacterial cold water disease-resistant and -susceptible rainbow trout lines and biomarker discovery. | Front Immunol | 2023 | 37928534 | PubTator, text mining | PubMed |
| One-dimensional H2V3O8 nanorods and two-dimensional lamellar MXene composites as efficient cathode materials for aqueous rechargeable zinc ion batteries. | RSC Adv | 2023 | 37920199 | PubTator, text mining | PubMed |
| Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome. | Front Immunol | 2023 | 37908345 | PubTator, text mining | PubMed |
| Eculizumab Versus Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome: A Systematic Review. | Cureus | 2023 | 37905269 | PubTator, text mining | PubMed |
| PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. | Nat Metab | 2023 | 37903887 | PubTator, text mining | PubMed |
| Prognostic Model and Tumor Immune Microenvironment Analysis of Complement-Related Genes in Gastric Cancer. | J Inflamm Res | 2023 | 37872955 | PubTator, text mining | PubMed |
| Role of the I416L Variant of Complement Factor I in Thrombotic Microangiopathy Among Patients of African Ancestry. | Kidney Int Rep | 2023 | 37849999 | PubTator, text mining | PubMed |
| Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation? | Int J Mol Sci | 2023 | 37833944 | PubTator, text mining | PubMed |
| Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis. | Front Med (Lausanne) | 2023 | 37809329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=6